Surgical Microscopes Market Growth, Trends and Value Chain 2020-2027

 The global surgical microscopes market is expected to grow significantly over the forecast period. The market held a market value of USD 574.34 million in 2017 and is projected to grow at a CAGR of 11.63% over the forecast period.

Surgical microscopes are the optical microscopes specially designed for the use in surgical settings. These surgical microscopes have a high magnification resolution which is highly beneficial during the microsurgeries. Also, surgical microscopes can be customized which is helpful for the component sterilization, and disinfection to ensure the complete cross-infection control. Generally, even the basic surgical microscopes can cost up to several thousand dollars. The advanced versions of such microscopes have high price points. There are several factors that fuel the growth of the global surgical microscopes market. These include, increasing number of surgical procedures, high demand for the minimally invasive surgeries, and continuous development in the medical sector to come up with better surgical approaches. Moreover, development of customized microscopy solutions, and increasing use of fluorescence image-guided surgery (FIGS) is expected to boost the growth of the market during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7065

On the other hand, there are several factors such as high cost of the microscopic devices, stringent regulatory norms, and lack of required medical infrastructure in the developing and underdeveloped regions which are likely to thwart the growth of the surgical microscopes market to an extent.

Segmentation

The global surgical microscopes market has been segmented into type, application and end user.

Based on types, the market has been segmented into, On casters microscopes, wall mounted microscopes, table top microscopes, and ceiling mounted microscopes. The on casters microscopes segment is expected to account for the largest share in the global surgical microscopes market in 2017. This large share is majorly attributed to its convenience in the use as compared to other products.

Based on application, the market has been segmented into neurosurgery & spine surgery, ophthalmology, ENT surgery, dentistry, oncology, plastic & reconstructive surgery, urology, gynecology, and other. The neurosurgery & spine surgery segment is expected to account for the largest share in the global surgical microscopes market in 2017 followed by ophthalmology segment.

Based on end users, the market has been segmented into hospitals, physician’s clinic, academic and research institutes, and other outpatient settings. The hospitals segment is expected to account for the largest share in the global surgical microscopes market in 2017. At the same time, the high awareness about the aesthetics, dental hygiene and increasing rate of ophthalmic surgical cases in the developed and developing countries has led physician’s clinic segment to grow at the fastest rate during the forecast period.

Based on the regions, the market for surgical microscopes is segmented in to, the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The surgical microscopes market in the Americas region has further been segmented into North America and South America, where-in the North American market is further divided into the US and Canada.

European surgical microscopes market has been segmented into Western Europe and Eastern Europe where-in Western Europe region is further divided into Germany, France, the UK, Italy, Spain, and the rest of Western Europe. 

The surgical microscopes market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The surgical microscopes market in the Middle East & Africa has been segmented into regions such as the Middle East & Africa.

Key players

Accu-Scope Inc., Alltion (Wuzhou) Co., Ltd., Arri Medical (Arri Group), Carl Zeiss AG, Danaher Corporation, Haag-Streit Surgical GmbH, Leica Microsystems GmbH, Novartis AG, Olympus Corporation, Seiler Precision Microscopes, Takagi Seiko Co. Ltd., and Topcon Medical Systems, Inc. are some of the key players in the global surgical microscopes market.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/surgical-microscopes-market-7065

Pipettes, Pipettors, and Accessories Market Growth, Trends and Value Chain 2020-2027

 Global pipettes, pipettors, and accessories market is anticipated to register a healthy CAGR over the forecast period. The market held a market value of USD 1,350.0 million in 2017 and is projected to grow at a CAGR of 4.1% during the forecast period. A pipette is a laboratory tool used in laboratories to transfer a measurable amount of liquid from one container to another. These are small tubes or slender graduated tubes of glass or plastic used in laboratories to transfer a measurable volume of liquid. A pipettor is an instrument used to dispense liquid while pipetting. Factors driving the market growth are rising investment in research and development (R&D) activities, increasing demand for accuracy, productivity, and quality in healthcare companies, growing focus on improving lab throughputs, and mounting applications in life sciences and biomedical research, pharmaceutical, environmental, chemical, and food processing industries. For instance, as per the data published by the International Federation of Pharmaceutical Manufacturers & Associations (IFPMA), in 2016 there were 6,861 drug entities in the preclinical regulatory phase that grew to 7,493 in 2017. In contrast, rapid development and launches of automatic and robotic-assisted liquid handling workstations are anticipated to restrain the market growth over the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/7015

Segmentation

The global pipettes, pipettors, and accessories market has been segmented into product and end user.

By product, the market has been segmented into pipettes, pipettors, and accessories. The pipettes segment is further categorized into beral/plastic/transfer/disposable pipettes, pasteur/glass pipettes/droppers, serological pipettes, volumetric/bulb pipettes, and others. The pipettors segment is sub-segmented into electronic pipettors and manual pipettors. These two pipettors are further separately categorized into single-channel pipettors and multichannel pipettors.

Based on end user, the market has been segmented into hospitals, laboratories, academic & research institutes, pharmaceutical & biotechnology companies, and others.

The global pipettes, pipettors, and accessories market has been segmented by region into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pipettes, pipettors, and accessories market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European pipettes, pipettors, and accessories market has been segmented into Western Europe and Eastern Europe. The Western Europe pipettes, pipettors, and accessories market has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.

The pipettes, pipettors, and accessories market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The pipettes, pipettors, and accessories market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players

Thermo Fisher Scientific Inc., BRAND GMBH + CO KG, CAPP ApS, Thomas Scientific, Inc., Corning Incorporated, Eppendorf AG, Gilson Incorporated, Hamilton Company, Greiner Bio-One International GmbH, INTEGRA Biosciences AG, The Lab Depot, Inc., Sartorius AG, Socorex Isba S.A., Nichiryo Co.,Ltd., and Mettler-Toledo International Inc. are some of the major players in the global pipettes, pipettors, and accessories market.

Regional Market Summary

Geographically, in 2017, the Americas commanded the global pipettes, pipettors, and accessories market due to the presence of pipettes & pipettors manufacturers, advanced technology used in medical devices, rising spending on healthcare, and mounting demand for these lab supplies in the US and Canada.

Europe is also expected to hold substantial market share over the forecast period due to the rise in research & development activities, the presence of favorable government policies related to healthcare infrastructure, the availability of well-developed lab facilities, and early adoption of novel technologies.

Asia-Pacific is likely to witness fastest CAGR from 2018 to 2023 attributed to increased burden of various diseases coupled with considerable funding support for clinical research and rising interest in scientific & industrial research to create new business opportunities.

The market in the Middle East & Africa would register the modest market growth rate from 2018 to 2023. Majority of the regional market is anticipated to be governed by the Middle East region due to increasing healthcare sector reforms.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/pipettes-pipettors-and-accessories-market-7015

Catheter Stabilization Device Market: Drivers, Restraints, Opportunities, and Threats (2020-2027)

 Global Catheter Stabilization Device Market is expected to register a CAGR of 7.1% during the forecast period of 2018 to 2023.Catheter stabilization device are the new standard of excellence for suture-free stabilization of biliary and nephrostomy percutaneous drainage, and peritoneal lavage catheters. These devices are used to secure catheters and infusion or drainage devices and to facilitate their operations. Furthermore, growing prevalence of cardiovascular diseases is driving the growth of the market. According to the World Health Organization in 2017, cardiovascular diseases were the main cause of the deaths across the global. It was estimated that in 2015, approximately 17.7 million people died from cardiovascular diseases, repressing 31% of all the global deaths. Of these deaths, an estimated 7.4 million were due to the coronary heart diseases and 6.7 million were due to stroke. Moreover in 2017, according to the American Heart Association, 801,000 deaths in the U.S. were accounted for the cardiovascular diseases. Moreover, the global cost for cardiovascular diseases is estimated to reach USD 1044 billion by 2030 from USD 863 billion in 2010.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/6944

Segmentation:

The Global Catheter Stabilization Device Market is segmented based on product type, application, end user, and region.On the basis of product type, the market is segmented into Arterial Securement Devices, Central Venous Catheter Securement Devices (further sub segmented into PICC Securement Devices, Subclavian Securement Devices, Midlines Securement Devices, Femoral Securement Devices, Portal Securement Devices, Jugular Securement Devices) Peripheral Securement Devices (further sub segmented into Foley Catheter Securement Devices, Nasogastric Tubes Securement Devices,  Endotracheal Tube Securement Devices, Ventriculoperitoneal Securement Devices, Continuous Nerve Block Catheter Securement Devices) Chest Drainage Tube Securement Devices, Abdominal Drainage Tubes Securement Devices (further sub segmented into Percutaneous Endoscopic Gastrostomy Securement Devices, Jejunal Catheter Securement Devices, Umbilical Catheter Securement Devices)Epidural Securement Devices. Further, on the basis of application the market is segmented into Cardiovascular Procedures, Respiratory Procedures, Gastric and Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology and Others. End users is segmented into Hospitals & Clinics, Home Healthcare Providers and Diagnostic Centers.

Regional Market Summary:

In the current scope of the study, the above-mentioned segments are covered into four global regions, namely- the Americas, Europe, Asia Pacific and the Middle East & Africa. The Americas dominated the Global market for catheter stabilization device owing to rising children population and presence of major market players within the region. According to the database of the U.S. Census Bureau, it was estimated that there were approximately 20,304,238 children who aged 5-9 years within the region. Moreover, the presence of developed economies and healthcare sector within the region boosts the market growth.

Europe accounted for the second largest market behind Americas. Europe consist of two regions namely Western Europe and Eastern Europe. Western Europe holds the major share of the market, which is majorly contributed by Germany, the U.K., and France. The major driving factor of the market are increasing prevalence of cardiovascular and chronic diseases. Additionally, according to the OECD, the healthcare expenditure in Germany was EUR 321 billion in 2014, which is followed by France with healthcare expenditure of EUR 237 billion. The healthcare expenditure of the U.K. in 2014 was EUR 223 billion. Healthcare organization in this region are able to afford the high cost of the treatment and devices, which has helped in driving the growth of the market. In addition to this, increasing government support and funding for the development and improving the technology have fuelled the growth of the market.

Asia Pacific is the fastest growing region in catheters market. Increasing need for better diagnostic devices, better and safe therapeutic approach, rapidly improving technology, and the presence of huge patient pool drive the growth of this market in Asia Pacific region. According to the ESCAP Statistical Database, in 2016, approximately 12.4% of the population in the Asia Pacific was over 60 years. According to the WHO, in 2013, the per capita healthcare expenditure in Australia was USD 6,110, which is followed by Japan with USD 3,966.

Catheter Stabilization Device Market Key players:

Some of the key players in the global catheter stabilization market are 3M Company, B. Braun Melsungen Ag, Baxter International, Inc., C. R. Bard, Inc., Centurion Medical Products, Convatec, Inc M.C. Johnson Company, Inc, Medtronic PLC, Merit Medical Systems, Inc, Smiths Group PLC, TIDI Products, LLC and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/catheter-stabilization-market-6944

Dental Surgical Instruments Market 2020 Analysis, Industry Size, Share Leaders, Current Status by Major vendors and Trends by Forecast to 2027

 Global Dental Surgical Instruments Market is expected to grow significantly over the forecast period. It is estimated that the Global Dental Surgical Instruments Market is valued at ,230 Million in 2017, with a CAGR of 6.0% during the forecast period of 2018–2023. The major factors influencing the growth of the market include increasing incidences of dental caries and other periodontal diseases, increasing number of dental professional, increasing growth dental expenditure and various others. Dental caries are the most common oral health diseases that are influencing the growth of the market. Increasing oral health problems among people are expected to increase the demand for advanced dental instruments, which is likely to enhance the market growth during the assessment period.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/6933

Periodontal diseases are more prevalent in the Asia-Pacific region. Lack of basic oral health education and limited availability of simple interventions such as pain relief and emergency care for acute infection and trauma to the majority of the population, especially in rural areas are major reasons for the high prevalence of periodontal diseases in the region. According to the FDI World Dental Federation, more than 80% of people in Asia including India, Bangladesh, Nepal, Malaysia, and Indonesia suffers from dental decay. Furthermore, 40 to 59% of the population in China and Australia suffers from dental decay. This high prevalence of dental decay triggers the demand for dental instruments, which in turn makes Asia pacific the fastest growing market.

However, factors such as high cost dental instruments and inadequate reimbursement policies for dental surgeries are expected hamper the growth of the market

Segmentation:

The Global Dental Surgical Instruments Market has been segmented into product type, therapeutic area, and end user.The market, on the basis of product type, has been segmented into instruments, and consumables. Furthermore, instruments have been segmented into handheld instruments, handpieces, lasers, electrosurgical systems, ultrasonic instruments. Moreover, handpieces are segmented into air-driven handpieces, electric handpieces & hybrid handpieces and lasers are segmented into soft-tissue lasers, & all-tissue lasersThe market, by therapeutic area, has been segmented into restorative dentistry, orthodontics, endodontics, and others.

The market, by end user, has been segmented into hospitals and dental clinics and others. The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Dental Surgical Instruments Market in the Americas has further been segmented into North America and South America, with the North American market divided into the US and Canada.

The European Dental Surgical Instruments Market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.  The dental surgical instruments market in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific. The Dental Surgical Instruments Market in the Middle East & Africa has been segmented into the Middle East and Africa.

Key players:

3M Company, A-Dec Inc.,  AMD Lasers, B. Braun Melsungen AG, Biolase, Inc., Brasseler USA, CAO Group, Inc., Coltene Holding AG, Danaher Corporation, Dentsply Sirona Inc., Helmut Zepf Medizintechnik GmbH, Hu-Friedy Manufacturing Company, LLC, Integra Lifesciences Holdings Corporation, Nakanishi Inc., Prima Dental Manufacturing Ltd., The Yoshida Dental Mfg. Co., Ltd.  among others are some of the key players in the Global Dental Surgical Instruments Market.

Regional Market Summary

Geographically, the Americas is anticipated to dominate the Global Dental Surgical Instruments Market. The large size of the market can be attributed to the higher adoption of various dental devices coupled with the presence of technologically advanced products. Earlier, periodontists were purchasing hospital format cyanoacrylate adhesive items that were intended for single-use wound closure circumstances in an emergency room setting. The formulations and packaging were not customized to the necessities of the dental industry. Moreover, the high disposable income of the region also enables professionals to opt for such devices. The occurrence of periodontal disease is on the rise in the US. According to the 2015 report suggested by the Centers for Disease Control and Prevention (CDC), nearly 47.2% of adults have some form of periodontal disease. It is also reported that the condition is more common in men than women. The healthcare transmission framework is changing quickly with the execution of the Affordable Care Act.

Europe is expected to hold the second largest position in the Global Dental Surgical Instruments Market.

Asia-Pacific is anticipated to be the fastest growing region in the market due to the presence of a huge dental patient population, continuously developing economies, and various others.

On the other hand, the Middle East & Africa has the least share of the market. Majority of the market of this region is expected to be held by the Middle East region due to growing healthcare expenditure.

Browse More Details of the Report @  https://www.marketresearchfuture.com/reports/dental-surgical-instruments-market-6933

Lancet and Pen Needles Market Growth, Trends and Value Chain 2020-2027

 Lancet and pen needles can be effectively used for the blood-based diagnosis, monitoring, and medication of diseases like diabetes and osteoporosis.  Pen needles are used in conjunction with the injection pens. Structurally, a pen needle consists of a hollow needle, which is embedded in a plastic hub and attaches to the injection pen. The lancet are double edged blades or needles and appears similar to the small scalpels. The market for lancet and pen needles is expected to grow at a healthy CAGR during the forecast period in the Asia Pacific region due to increasing prevalence of diseases like diabetes and osteoporosis. According to a study conducted by the American Diabetes Association in 2016, about 80% of the diabetic patients resides in the developing countries and it is estimated that the rise of type 2 diabetes in South Asia is likely to be 150% between 2000 and 2035. Moreover, in the Western Pacific region, the number of diabetic patients is expected to reach 201.8 million by 2035. Additionally, according to the International Osteoporosis Foundation by 2050, over ~50% of all osteoporotic hip fractures are expected to occur in Asia. Factors such as increasing geriatric population and growing healthcare expenditure along with favourable government policies are projected to boost the market growth during the forecast period.  However, the need to remove the pin after a single use and high cost as compared to the insulin vials may restrain the market growth during the forecast period.

Browse Sample of the Report @  https://www.marketresearchfuture.com/sample_request/630

The Asia Pacific lancet and pen needles market is expected to grow at an approximate CAGR of 6.5% during the forecast period, 2017-2023.

Intended Audience

• Pharmaceutical companies
• Biotechnological institutes
• Government and Private Laboratories
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Market Research and Consulting Service Providers

Segmentation

The Asia Pacific lancet and pen needles market is segmented on the basis of therapy, gauge, needle length, and end users.

On the basis of the therapy, the market is segmented into insulin, glucagon-like peptide-1 (GLP-1), growth hormones, and others.

On the basis of the gauge, the market is categorized into 17/18G, 21G, 23G, and others.

On the basis of the needle length, the market is segmented into 4mm, 8mm, 12mm, and others.

On the basis of the end users, the market is segmented into hospitals & clinics, medical institutions & research organizations, and others.

Regional Analysis

On the regional basis, Asia Pacific is segmented into Japan, India, China, the Republic of Korea, Australia, and the Rest of Asia Pacific.

Japan holds a major share of the market followed by the Republic of Korea and Australia owing to the well-developed healthcare sector and high per capita healthcare expenditure. In 2014, according to the Statistics Bureau, Japan’s total medical care expenditure was about 11.20% of the national income, which accounted for USD 0.37 trillion. Additionally, favorable governmental policies boost the market growth in these regions.

China and India have a growing market due to huge population base, increasing demand for the better quality products, rapidly changing the economy, increasing healthcare expenditure, and rising number of pharmaceutical & biotechnological companies. Moreover, increasing number of healthcare organizations like a hospital, the private research institute has led to increasing in the market in India. Rest of Asia Pacific holds the least share of the market.

 

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/asia-pacific-lancet-pen-needels-market-630

Sterility Testing Market Growth, Trends and Value Chain 2020-2027

 The global sterility testing market is anticipated to reach USD 1,245.2 million by 2023, as per a new detailed report by Market Research Future (MRFR). It is expected to exhibit an 11.7% CAGR during the assessment period (2017-2023). High prevalence of cardiovascular diseases and various cancers are expected to induce market demand. Government support in terms of funding coupled with the expanding life science sector is anticipated to bode well for the market during the forecast period.

Sterility testing is essential for research and development purposes in pharmaceutical companies. It is a crucial step for determining the safety of drugs before consumption. In addition, sterility testing is also conducted in specific rooms in facilities to keep it germ-resistant. Drugs and vaccines undergone sterility testing can be commoditized and made commercially available to the masses. This can be beneficial to patients afflicted with cancer and cardiovascular diseases.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/547

Report Overview

This report allows the user to gain a deeper understanding of the ongoing events and trends in the global market for sterility testing. By correlating the historical data with key market dynamics, analysts were able to make highly accurate projections in the report. MRFR’s report includes a thorough segmental analysis of the global sterility testing market segmented by product type, test type, end-user, and region with astute insights. This report has been prepared to assist industry participants in making informed decisions on growth strategies and operation management. Users will also come across drivers, trends, opportunities, and restraints which are likely to influence the growth of the market during the assessment period.

Segment Overview

By product type, the sterility testing market has been segmented into instruments, consumables, and services. The services segment is further segmented into sterility assurance tests, sterility validations, cleaning and disinfection, and stability testing. By test type, the market is segmented into product flush sterility testing, membrane filtration sterility testing, direct transfer sterility testing, and others. By end-user, the market is segmented into academic and research laboratories, pharmaceutical companies, hospitals and clinics, and others.  

The segments and sub-segments covered in the report are analyzed under four major regions –Americas, Europe, Asia Pacific (APAC), and the Middle East and Africa (MEA), with respective country-level market sizing. For the scope of research, the standard definition of the product/ service “sterility testing” is included in the report. The report discusses and interprets the current and future opportunities of the industry delivering an unbiased growth assessment.

Players Covered

Bioquell U.K. Ltd., Belimed Deutschland GmbH, Baxter BioPharma Solutions, Charles River Laboratories Inc., Boston Scientific Corporation, BioMérieux SA, Thermo Fisher Scientific Inc., SGS SA, Pacific BioLabs Inc., WuXi AppTec, Astell Scientific, Sartorius AG, Becton, Dickinson and Company, Merck KGaA, and others are prominent players in the sterility testing market.

The report offers comprehensive profiles on these market players and assesses their current standing in the sterility testing market. Company history coupled with annual turnover, segmental share, SWOT analysis, growth strategies, new product launches, M&A activities, and latest R&D initiatives are outlined in the report.

Research Methodology

Market Research Future (MRFR) uses a combination of primary and secondary research to compile market reports. Primary data is accumulated from interviewing industry stalwarts and secondary research is collated by studying white papers and annual reports of leading players. Our analysts use top-down and bottom-up approaches to validate the findings of the report. The report consists of news, current trends, and future prospects related to the market, all of which can provide a thorough understanding of the market to clients. Industry leaders can make accurate business decisions based on our insights.

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/sterility-testing-market-547

Ischemic stroke Market Growth, Trends and Value Chain 2020-2027

 Ischemic strokes occur as a result of an obstruction within a blood vessel supplying blood to the brain. The underlying condition of this type of obstruction is the development of fat deposits lining the vessel walls, which is known as atherosclerosis. According to the World Health Organization (WHO), stroke accounts for around 17 million deaths annually. As per the Centers for Disease Control and Prevention (CDC), stroke leads to 1 out of every 20 deaths costing around USD 34 billion each year in the U.S. Higher rates of mortality associated with strokes highlight an impending need for innovative drugs and diagnostic devices.

The key strategies adopted by leading industry players incldues new product launches and collaborations. For instance, in April 2016, the novel TransCarotid Artery Revascularization (TCAR) procedure launched by Silk Road Medical, Inc, received FDA approval. This minimally invasive technique is designed to access the common carotid artery. Moreover, in March, 2015, WATCHMAN, a closure device designed to prevent stroke in patients with atrial fibrillation received FDA approval.

Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5423

Rising cases of ischemia stroke are driving the demand for surgical procedures in stroke treatment. Increasing demand for minimally invasive procedures and advancements in surgical procedures are the key factors boosting the growth of the global ischemic stroke market. High cost of the surgical procedures and excessive usage of medication for the treatment of ischemic stroke are hindering the market growth.

The global market for ischemic stroke is expected to grow at a CAGR of approximately 8.3% during the forecast period 2017-2023.

Intended Audience:

• Ischemic Stroke Drug Suppliers
• Ischemic Stroke Drug Manufacturers
• Research and Development (R&D) Companies
• Medical Research Laboratories
• Academic Medical Institutes and Universities

Segmentation:

The ischemic stroke is segmented on the basis of diagnosis, drug class, surgery and end-users.

On the basis of the diagnosis, the market is segmented into Computed Tomography (CT), Magnetic resonance imaging (MRI), carotid ultrasound, cerebral angiography, electrocardiography, echocardiography, and others.

On the basis of the drug class, the market is segmented into tissue plasminogen activator, anticoagulant, antiplatelet, antihypertensive, and others

On the basis of the surgery, the market is segmented into carotid endarterectomy, angioplasty, and endovascular mechanical thrombectomy

On the basis of the end-user, the market is segmented into hospitals & clinics, medical institutes, research organization, and others.

Regional Analysis:                     

The global ischemic stroke market consists of countries namely America, Europe, Asia Pacific, and the Middle East and Africa.

The Americas has emerged as the largest market for the global ischemic stroke owing to the favorable government initiatives, technological innovations, and increasing demand for ischemic stroke products. According to the American Heart Association, ischemic stroke is among the top three causes of death in the U.S. and Canada, nearly 795,000 patients suffering from strokes are treated in the 2014.

Europe is the second largest global ischemic stroke market owing to the advancements in the surgical devices technology along with the rising occurrence of acute ischemia stroke cases among the patients. In the European Union, over 31 million people are living with diabetes aged between 20 and 79. This signifies an average diabetes prevalence rate of 8.6% of the adult population. Some other factors driving the market includes the growing percentage of diabetes mellitus population mainly in the developed countries of Europe

Asia Pacific is anticipated to unfold as the most promising market for the global ischemic stroke owing to increasing prevalence of stroke cases in this region. China and India are considered as a big market for ischemic stroke within the forecast period. Manufacturers are expanding their operations in Asia Pacific region as these regions hold immense potential for the market growth.

The Middle East region is expected to grow at a faster rate due to the factors such as the extensive development of healthcare infrastructure and growing emphasis on research and development in the healthcare sector.

Key Players:

The emergence of new and cost-effective medication options for the treatment of ischemic stroke could open up new opportunities to the new players in the global ischemic stroke market. Additionally, emerging markets, such as India and China, could also open new opportunities to new players.

Some of key the players in the Americas ischemic stroke market are Abbott Laboratories (U.S.), Medtronic plc (U.S.), Boston Scientific Corporation (U.S.), Cordis Corporation (U.S.),  Koninklijke Philips N.V. (Netherland), GE Healthcare (U.S.), Stryker Corporation (U.S.), Genentech, Inc. (U.S.), Merck & Co., Inc. (U.S.),  Bayer AG (Germany), Boehringer Ingelheim (Germany), Sanofi (France), Covidien plc (Ireland), Philips Healthcare (U.S.), Johnson & Johnson (U.S.), Penumbra, Inc. (U.S.),  GE Healthcare (U.S.),  Siemens Healthcare (U.S.), Hitachi, Ltd (Japan), Biogen (U.S.), Daiichi Sankyo (U.S.), Pfizer Inc. (U.S.), and others

Browse More Details of the Report @ https://www.marketresearchfuture.com/reports/ischemic-stroke-market-5423